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Abstract
Introduction: Liver injury is a frequent complication associated with anorexia nervosa, and steatosis of the liver is
thought to be the major underlying pathology. However, acute hepatic failure with transaminase levels over 1000
IU/mL and deep coma are very rare complications and the mechanism of pathogenesis is largely unknown.
Case presentation: A 37-year-old Japanese woman showed features of acute liver failure and hepatic coma which
were not associated with hypoglycemia or hyper-ammonemia. Our patient’s consciousness was significantly
improved with the recovery of liver function and normalization of transaminase levels after administration of
nutritional support.
Conclusions: Our case report demonstrates that transaminase levels had an inverse relationship with the
consciousness of our patient, although the pathogenesis of coma remains largely unknown. This indicates that
transaminase levels can be one of the key predictors of impending coma in patients with anorexia nervosa.
Therefore, frequent monitoring of transaminase levels combined with rigorous treatment of the underlying
nutritional deficiency and psychiatric disorder are necessary to prevent this severe complication.
Introduction
Anorexia nervosa (AN) is a difficult-to-treat psychoso-
matic disease. Mild liver injury is regularly detected as a
complication of AN [1-5]. Although severe acute liver
injury has been previously described in a patient with
AN, the underlying pathogenetic mechanisms remain
largely unclear. Furthermore, only a few cases of AN
with deep coma have been reported, mostly due to
hypoglycemic coma [6-9].
Our case report describes a patient with AN who
rapidly developed deep coma associated with acute liver
failure, which was rapidly improved by initiation of total
parenteral nutrition (TPN) and enteral feedings via a
nasogastric (NG) tube.
Case presentation
Our patient was a 37-year-old Japanese woman with a
12-year history of AN. She had been hospitalized fre-
quently in the gastrointestinal unit for nutritional treat-
ment, but she continuously rejected hospitalization in a
psychiatric unit probably due to her denial of the illness,
despite her frequent, self-induced vomiting. She had been
admitted to the hospital three times previously because of
general fatigue combined with acute liver failure. At these
admissions, her Glasgow coma scale (GCS) was in the
normal range of 12 to 15. She was strongly recommended
to consult a psychiatrist, b u tt u r n e dd o w nt h ea d v i c e
because of denial of her AN. Therefore, she was only pre-
scribed ursodeoxycholic acid, multivitamin, and an ent-
eral nutritional supplement. She had never previously
received any psychotherapy. Furthermore, she had no
history of alcohol abuse, anti-depressant drug intake,
narcotic drug abuse or suicide attempt.
On the three prior admissions, physical examination
had revealed severe emaciation, with a weight of 29.0 kg
and a height of 1.52 m (body mass index (BMI) = 12.6).
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sure was around 85/50 mm/Hg, with a regular heart
rate of around 80 beats per minute.
At the time of her fourth admission, she was in a deep
coma with a GCS score of 3. Arterial blood gas analysis
revealed an arterial oxygen concentration of 97% in
room air. The electrocardiogram showed sinus rhythm
and a heart rate of 88 beats per minute. She had a
weak, but positive papillary response without papillary
mydriasis or miosis. Her body temperature was 35.6°C.
T h e r ew e r en os i g n so fr e s p i r a t o r yo rc a r d i a cd i s e a s e .
Her blood sugar level was 68 at the time of admission,
in the range of her usual level of 50 to 70. Computed
tomography (CT), magnetic resonance imaging, and
magnetic resonance angiography of the head showed no
abnormality.
Aspartate aminotransferase was 3194 IU/L (reference
range, 7 to 38 IU/L); alanine aminotransferase, 3540
IU/L (4 to 44 IU/L); alkaline phosphatase, 2388 IU/L
(100 to 320 IU/L); g-glutamyl transpeptidase, 342 IU/L
(2 to 40 IU/L); NH3,5 1μg/dL (40 to 80 μg/dL). The
ratio of branched-chain amino acids versus aromatic
amino acids (BCAA/AAA) was 3.8 (2.5 to 3.5); albu-
min was 3.6 g/dL (3.8 to 5.3 g/dL); total bilirubin,
1.7 mg/dL (0.2 to 1.0 mg/dL); total cholesterol,
117 mg/dL (130 to 220 mg/dL); prothrombin activity,
49.8% (80 to 120%); hepaplastin test, 50.1% (70 to
130%); Type IV 7S-collagen, 4.9 ng/mL (< 6.0 ng/mL);
HbA1c, 4.0% (4.3 to 5.8%); blood urea nitrogen,
23.6 mg/dL (8.0 to 20.0 mg/dL); creatinine, 0.69 mg/
dL (0.3 to 0.8 mg/dL); white blood cells, 4070/mL
(3800 to 9300/mL); hemoglobin, 12.1 g/dL (11.5 to
15.0 g/dL); hematocrit, 34.5% (33.5 to 44.5%); Fe,
123 μg/dL (48 to 154 μg/dL); Cu, 78 μg/dL (66 to
130 μg/dL); Zn, 92 μg/dL (59 to 135 μg/dL); platelet
count, 12.7 × 10
4/μL( 1 3t o3 7×1 0
4/μL); and total
protein, 5.0 g/dL (6.5 to 8.2 g/dL). Anti-nuclear and
anti-mitochondrial antibodies were negative. Serologic
tests for hepatotropic viruses (hepatitis A, B, and C
viruses, cytomegalovirus, and Epstein-Barr virus) and
the urinary toxicology screen (alcohol, cannabis,
cocaine, paracetamol, amphetamines, benzodiazepines,
methadone, opiates) were negative. Ultrasound showed
a mild fatty liver, but the CT score (Hounsfield units)
of the liver was slightly higher than that of the spleen
(data not shown).
The NH3 and BCAA/AAA levels remained normal
during our patient’s coma and afterward, and the blood
sugar remained close to her usual level (Table 1). TPN
and enteral tube feeding were administered on the day
of admission. Her consciousness gradually normalized at
day 10, which was paralleled with an improvement of
her severe liver dysfunction (Table 1). Comparing the
broad spectrum of laboratory clinical parameters with
her GCS level, only serum transaminases showed a
strong inverse correlation. Of note, blood sugar, plasma
NH3, and the BCAA/AAA ratio were not correlated
with her consciousness. A liver biopsy was performed
after the recovery of her liver function at day 14.
Ballooning of hepatocytes, necroinflammatory changes,
and macrovesicular steatosis were observed in hematox-
ylin-eosin-stained sections (Figure 1), but both iron and
copper staining were negative (data not shown).
No etiology of the deep coma, other than acute malnu-
trition-induced liver injury, was detected.
Discussion
To the best of our knowledge, this is the first report of a
patient with AN presenting with deep coma associated
with acute hepatitis/liver failure. AN is an eating disor-
der, affecting mainly young women with a distorted
b o d yi m a g ea n dao v e r w h e l m i n gd e s i r et ob es l i m .
Minor degrees of liver injury have been reported in up
to 40% of patients with AN [5]. Although the mechan-
ism of liver injury in AN has been thought to be due to
protein-calorie malnutrition of the Kwashiorkor-type
with fatty changes, this has not been rigorously demon-
strated, and the precise mechanism is still unknown
[10]. Starvation-induced autophagy of hepatocytes [11]
and enhanced starvation-induced hepatocyte oxidative
stress may be a leading mechanism resulting in liver
dysfunction in AN [12]. In the latter report, the CT den-
sity of the liver was higher than that of the spleen in a
patient with AN and elevated transaminases, whereas
liver steatosis was diagnosed in ultrasound imaging, as
was found in our patient. In addition, these authors
detected increased markers of oxidative stress in the
liver biopsy. Again, this is compatible with our finding
of numerous hepatocytes with signs of ballooning
(Figure 1), which is a hallmark of oxidative stress and of
hepatocyte apoptosis and autophagy in alcoholic and
non-alcoholic steatosis [13]. These reports, in conjunc-
tion with our findings, strongly indicate that starvation
in AN patients leads to enhanced oxidative stress, hepa-
tocyte apoptosis, and autophagy that trigger acute liver
inflammation and moderate functional liver failure. To
date, only rare cases describe coma in AN patients,
most of them due to hypoglycemia [6-9]. Hypoglycemia
could be ruled out in our case. Interestingly, an inverse
relationship was noted between the GCS and the transa-
minase levels (Table 1). This further supports the
previously mentioned sequence in which acute starva-
tion-induced liver injury apparently promoted the devel-
opment of hepatocyte necrosis/autophagy, liver
dysfunction, and deep coma in a patient with AN. How-
e v e r ,t h i sh y p o t h e s i sd o e sn o tn e c e s s a r i l ya p p l yt oa l l
patients with severe hepatitis, because a case of a patient
with AN with clear consciousness despite highly
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case is different from other cases of acute or chronic or
liver failure, in that the circulating type IV 7S-collagen,
the BCAA/AAA ratio, and the NH3 level remained nor-
mal during several days of deep coma. Recently, in two
patients with AN and normal transaminase levels, iatro-
genic hyperammonia induced by high-protein dietary
supplements was reported [15]. In our case, coma gra-
dually disappeared with improvement of nutritional sta-
tus and liver injury, but was unrelated to the NH3 level,
usually a strong predictor of encephalopathy in acute or
cirrhotic liver failure [15]. The clinical data clearly indi-
cated that the transaminase levels had a strong inverse
correlation with our patient’s consciousness. These
results strongly suggest that the pathogenesis of coma in
classic hepatic encephalopathy differs from that in our
patient with AN.
Conclusions
Our case report of a patient with AN and high transami-
nase levels in a deep coma indicates that severe starvation-
induced hepatocyte autophagy and apoptosis may lead to
a diagnosis of acute liver failure. However, in contrast to
hepatic encephalopathy, neither blood ammonia levels nor
the ratio of BCAA/AAA was abnormal. We hypothesize
that patients with AN and mild liver dysfunction may
develop lower degrees of encephalopathy that may escape
routine detection. Therefore, it is necessary to monitor
transaminase levels regularly in patients with AN.
It is important to note that the severe hepatitis and
encephalopathy observed in our patient were completely
reversed after institution of appropriate parenteral and
enteral nutrition. We hope that psychiatric therapy will
remain the mainstay of treating patients with AN,
preventing severe malnutrition with subsequent liver
dysfunction, as was diagnosed in our patient.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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Table 1 Laboratory data at admission and during hospitalization.
Day 1 Day 2 Day 3 Day 4 Day 5 Day 7 Day 10 Day 14 Day 19 Day 25 Day 32
AST (IU/L) (7-38) 3194 4880 2556 1614 1567 1021 807 455 138 86 45
ALT (IU/L) (4-44) 3540 5408 4056 3672 2440 1958 1492 859 434 137 70
ALP (IU/L) (100-320) 2388 3282 2872 2732 1948 1649 1080 741 651 524 482
T-BIL (mg/dL) (0.2-1.0) 1.7 2.3 2.7 2.2 2.5 2.1 2.0 1.4 1.5 1.2 0.9
ALB (g/dL) (3.8-5.3) 3.1 3.6 3.3 3.1 3.4 3.3 3.3 3.5 3.2 2.8 2.9
NH3 (μg/dL) (40-80) 51 28 69 33 36 73 88 90 77 80 80
PTA (%) (80-120) 49.8 44.6 48.3 54.5 67.9 79.4
BS (mg/dL) (70-160) 68 98 89 102 94 87 85 68 66 58 62
BCAA/AAA (2.5-4.5) 3.8 3.6 3.3 4.0 3.1 3.2
GCS (15) 3 3 4 5 7 10 15 15 15 15 15
Figure 1 Hematoxylin-eosin staining of liver biopsy specimen
of the patient with anorexia nervosa. Diffuse macrovesicular
steatosis as well as numerous ballooning hepatocytes.
Necroinflammatory changes representing acidophilic bodies and
spotty necrosis (arrowheads).
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